American Financial Tribune: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Financial Tribune.

Press releases published on May 30, 2026

May 30, 2026

Market Logic Network Expands Revenue Operations Systems for Connected Business Growth

Indeterminate EIN Presswire

May 30, 2026

HSA for America Urges Americans to Start Open Enrollment Planning Now, Not in November

Indeterminate EIN Presswire

May 30, 2026

Creality Charts Next Decade as AI-Powered Consumer 3D Creative Platform

Indeterminate EIN Presswire

May 30, 2026

GOSS DEADLINE NOTICE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Gossamer Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 1 Deadline in Securities Class Action – GOSS

Indeterminate GlobeNewswire

May 30, 2026

UPST DEADLINE NOTICE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Upstart Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 8 Deadline in Securities Class Action – UPST

Indeterminate GlobeNewswire

May 30, 2026

Eikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology

Indeterminate GlobeNewswire

May 30, 2026

Globale Daten der ROSETTA Lung-02-Studie: Ermutigende Wirksamkeit für BioNTechs und Bristol Myers Squibbs bispezifischen PD-L1xVEGF-A-Immunmodulator-Kandidat Pumitamig bei nicht-kleinzelligem Lungenkrebs

Indeterminate GlobeNewswire

May 30, 2026

Global Data for BioNTech and Bristol Myers Squibb’s PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial

Indeterminate GlobeNewswire

May 30, 2026

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages POET Technologies Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – POET

Indeterminate GlobeNewswire

May 30, 2026

Mineralys Therapeutics Presents New Data from the Phase 3 Launch-HTN Trial of Lorundrostat in Participants with Hypertension and Chronic Kidney Disease at European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)

Indeterminate GlobeNewswire

May 30, 2026

NUAI DEADLINE MONDAY: ROSEN, NATIONAL TRIAL LAWYERS, Encourages New Era Energy & Digital, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 1 Deadline in Securities Class Action – NUAI

Indeterminate GlobeNewswire

May 30, 2026

Immatics Presents Clinical Activity of IMA203CD8 PRAME Cell Therapy in Hard-to-Treat Gynecologic Cancers at 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire

May 30, 2026

Molecular Partners Holds Presentations at ASCO and SNMMI 2026 on DLL3-Targeting Radio-DARPin MP0712, Now Dosing Patients in Phase 1

Indeterminate GlobeNewswire

May 30, 2026

Cogent Biosciences Announces Detailed Clinical Data from PEAK Phase 3 Trial with Bezuclastinib in Combination with Sunitinib in Gastrointestinal Stromal Tumors (GIST) at 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

Indeterminate GlobeNewswire

May 30, 2026

Replimune Presents 3-Year Landmark Overall Survival Analysis from IGNYTE Clinical Trial During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting

Indeterminate GlobeNewswire

May 30, 2026

James Altucher: "Nobody's Ready for What Happens After June 8"

Indeterminate GlobeNewswire

May 30, 2026

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Immutep Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IMMP

Indeterminate GlobeNewswire

May 30, 2026

James Altucher Says You Have Weeks to Understand the Biggest IPO in History

Indeterminate GlobeNewswire

May 30, 2026

BRCB INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Black Rock Coffee Bar, Inc.

Indeterminate GlobeNewswire

May 30, 2026

MZTI INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving The Marzetti Company

Indeterminate GlobeNewswire